Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Agius

Showing results (221-230 of 228) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 228 results.
Psychiatria Danubina|September 3, 2013
Comparing a Community Mental Health team in Bedford (UK) with Community Mental Health Services in Perugia (Italy): description of teams and caseloadsSandro Elisei, Mark Agius, Eva Nora Bongards, et al.
Muscle & Nerve|August 21, 2003
Rapsyn mutations in myasthenic syndrome due to impaired receptor clusteringRicardo A Maselli, Vanessa Dunne, Samuel Ignacio Pascual-Pascual, et al.
Journal of the Neurological Sciences|May 22, 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialSamuel F Hunter, Mark Agius, Deborah M Miller, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisBruce Hughes, Mark Cascione, Mark S Freedman, et al.
Psychiatria Danubina|September 28, 2012
Early intervention program for psychotic disorders at the psychiatric hospital "Sveti Ivan"Branka Restek-Petrović, Mate Mihanović, Majda Grah, et al.
Psychiatria Danubina|September 25, 2016
Thinking of psychiatric disorders as "normal" illness. Data from a questionnaire on social stigma: a multicenter studyMaurilio Giuseppe Maria Tavormina, Giuseppe Tavormina, Eugenio Nemoianni, et al.
BMC Psychiatry|April 4, 2014
Distribution of tract deficits in schizophreniaIan Ellison-Wright, Pradeep J Nathan, Edward T Bullmore, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Pageof 23

Showing results (221-230 of 228) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 228 results.
Psychiatria Danubina|September 3, 2013
Comparing a Community Mental Health team in Bedford (UK) with Community Mental Health Services in Perugia (Italy): description of teams and caseloadsSandro Elisei, Mark Agius, Eva Nora Bongards, et al.
Muscle & Nerve|August 21, 2003
Rapsyn mutations in myasthenic syndrome due to impaired receptor clusteringRicardo A Maselli, Vanessa Dunne, Samuel Ignacio Pascual-Pascual, et al.
Journal of the Neurological Sciences|May 22, 2016
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trialSamuel F Hunter, Mark Agius, Deborah M Miller, et al.
Multiple Sclerosis and Related Disorders|August 13, 2015
First-dose effects of fingolimod after switching from injectable therapies in the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosisBruce Hughes, Mark Cascione, Mark S Freedman, et al.
Psychiatria Danubina|September 28, 2012
Early intervention program for psychotic disorders at the psychiatric hospital "Sveti Ivan"Branka Restek-Petrović, Mate Mihanović, Majda Grah, et al.
Psychiatria Danubina|September 25, 2016
Thinking of psychiatric disorders as "normal" illness. Data from a questionnaire on social stigma: a multicenter studyMaurilio Giuseppe Maria Tavormina, Giuseppe Tavormina, Eugenio Nemoianni, et al.
BMC Psychiatry|April 4, 2014
Distribution of tract deficits in schizophreniaIan Ellison-Wright, Pradeep J Nathan, Edward T Bullmore, et al.
Contemporary Clinical Trials|August 14, 2016
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosisRobert J Fox, Christopher S Coffey, Merit E Cudkowicz, et al.
Pageof 23